Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Capital Expenditures (2016 - 2024)

HealthLynked (HLYK) has disclosed Capital Expenditures for 8 consecutive years, with $2598.0 as the latest value for Q1 2024.

  • On a quarterly basis, Capital Expenditures changed N/A to $2598.0 in Q1 2024 year-over-year; TTM through Dec 2024 was $2598.0, a 67.61% increase, with the full-year FY2024 number at $2598.0, up 73.2% from a year prior.
  • Capital Expenditures was $2598.0 for Q1 2024 at HealthLynked, up from $1550.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $22014.0 in Q1 2022 to a low of $1550.0 in Q2 2022.
  • A 4-year average of $8421.0 and a median of $7087.0 in 2021 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: plummeted 51.66% in 2021, then surged 197.53% in 2022.
  • HealthLynked's Capital Expenditures stood at $11456.0 in 2020, then plummeted by 40.86% to $6775.0 in 2021, then plummeted by 77.12% to $1550.0 in 2022, then surged by 67.61% to $2598.0 in 2024.
  • Per Business Quant, the three most recent readings for HLYK's Capital Expenditures are $2598.0 (Q1 2024), $1550.0 (Q2 2022), and $22014.0 (Q1 2022).